RAG2 and neoplasm: Wild-type and RAG2-deficient mice displayed comparable initial tumour burdens (Extended Data Fig. 2a); however, after 14 days, immunocompetent mice demonstrated local rejection of around 30% of individual tumours from the same array, while immunodeficient mice did not reject the tumours (Fig. 1b,c and Extended Data Fig. 2b).